BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 22826612)

  • 1. Natural history of Barrett's esophagus.
    Milind R; Attwood SE
    World J Gastroenterol; 2012 Jul; 18(27):3483-91. PubMed ID: 22826612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Barrett's Esophagus and Esophageal Carcinoma.
    Fabian T; Leung A
    Surg Clin North Am; 2021 Jun; 101(3):381-389. PubMed ID: 34048759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention in Barrett's oesophagus.
    Gordon V; Jankowski J
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):569-79. PubMed ID: 22122772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and surveillance for complications related to gastroesophageal reflux disease.
    Spechler SJ
    Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.
    Dent J
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():11-30. PubMed ID: 21199510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
    Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
    Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving management of metaplasia and dysplasia in Barrett's epithelium.
    Evans RP; Mourad MM; Fisher SG; Bramhall SR
    World J Gastroenterol; 2016 Dec; 22(47):10316-10324. PubMed ID: 28058012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of Barrett's esophagus: 1980-2003.
    Csendes A
    World J Surg; 2004 Mar; 28(3):225-31. PubMed ID: 14961203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of young patients with early Barrett's neoplasia.
    Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
    World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.
    Sharma P; Katzka DA; Gupta N; Ajani J; Buttar N; Chak A; Corley D; El-Serag H; Falk GW; Fitzgerald R; Goldblum J; Gress F; Ilson DH; Inadomi JM; Kuipers EJ; Lynch JP; McKeon F; Metz D; Pasricha PJ; Pech O; Peek R; Peters JH; Repici A; Seewald S; Shaheen NJ; Souza RF; Spechler SJ; Vennalaganti P; Wang K
    Gastroenterology; 2015 Nov; 149(6):1599-606. PubMed ID: 26296479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.